nitroaspirin has been researched along with naproxen in 7 studies
| Studies (nitroaspirin) | Trials (nitroaspirin) | Recent Studies (post-2010) (nitroaspirin) | Studies (naproxen) | Trials (naproxen) | Recent Studies (post-2010) (naproxen) |
|---|---|---|---|---|---|
| 127 | 9 | 8 | 4,551 | 1,057 | 1,429 |
| Protein | Taxonomy | nitroaspirin (IC50) | naproxen (IC50) |
|---|---|---|---|
| Prostaglandin G/H synthase 1 | Ovis aries (sheep) | 1.1642 | |
| Hormone-sensitive lipase | Rattus norvegicus (Norway rat) | 1.2 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 4.0203 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 3.8725 | |
| Prostaglandin G/H synthase 2 | Rattus norvegicus (Norway rat) | 0.06 | |
| Aldo-keto reductase family 1 member C3 | Homo sapiens (human) | 0.5867 | |
| Aldo-keto reductase family 1 member C2 | Homo sapiens (human) | 1.26 | |
| Prostaglandin G/H synthase 2 | Ovis aries (sheep) | 3.36 | |
| Solute carrier family 22 member 6 | Homo sapiens (human) | 5.8 | |
| Prostaglandin G/H synthase 1 | Rattus norvegicus (Norway rat) | 0.06 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antonelli, E; Cirino, G; Coata, G; Distrutti, E; Federici, B; Fiorucci, S; Morelli, A; Morelli, O; Renzo, GD; Santucci, L; Soldato, PD | 1 |
| Kalofonos, H; Lebovics, E; Rigas, B; Vagenakis, AG | 1 |
| Breese, E; Del Soldato, P; Mitchell, J; Warner, T; Wood, E; Zacharowski, P | 1 |
| Cirino, G; Distrutti, E; Wallace, JL | 1 |
| Antonelli, E; Fiorucci, S | 1 |
| Ji, H; Peng, SX; Zhang, YH | 1 |
| Aisa, MC; Datti, A; Di Renzo, GC; Orlacchio, A | 1 |
4 review(s) available for nitroaspirin and naproxen
| Article | Year |
|---|---|
NO-NSAIDs and cancer: promising novel agents.
Topics: Animal Experimentation; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Aspirin; Cell Line, Tumor; Humans; In Vitro Techniques; Naproxen; Nitric Oxide; Rats | 2003 |
Nitric oxide and inflammation.
Topics: Acetaminophen; Animals; Anti-Inflammatory Agents; Aspirin; Clinical Trials as Topic; Drug Evaluation, Preclinical; Humans; Inflammation; Naproxen; Nitrates; Nitric Oxide | 2006 |
NO-NSAIDs: from inflammatory mediators to clinical readouts.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Blood Coagulation; Cardiovascular Diseases; Chemotaxis, Leukocyte; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Cytokines; Endothelial Cells; Gastrointestinal Tract; Gene Expression Regulation; Humans; Leukocytes; Macrophages; Mitochondria; Naproxen; Nitrates; Nitric Oxide; Nitric Oxide Synthase Type II; Platelet Aggregation | 2006 |
[A novel class of anti-inflammatory and analgesic drugs--NO-donating NSAIDs].
Topics: Acetaminophen; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiotonic Agents; Cyclooxygenase Inhibitors; Flurbiprofen; Gastrointestinal Diseases; Humans; Ibuprofen; Naproxen; Nitrates; Nitric Oxide Donors | 2007 |
3 other study(ies) available for nitroaspirin and naproxen
| Article | Year |
|---|---|
Nitric oxide-releasing NSAIDs inhibit interleukin-1beta converting enzyme-like cysteine proteases and protect endothelial cells from apoptosis induced by TNFalpha.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Caspase Inhibitors; Cell Line; Cysteine Proteinase Inhibitors; DNA Fragmentation; Endothelium, Vascular; Flurbiprofen; Gastric Mucosa; Humans; In Situ Nick-End Labeling; Male; Mice; Naproxen; Nitric Oxide; Peroxidase; Rats; Rats, Wistar | 1999 |
NSAIDs increase GM-CSF release by human synoviocytes: comparison with nitric oxide-donating derivatives.
Topics: 1-Methyl-3-isobutylxanthine; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blotting, Western; Cells, Cultured; Cyclic AMP; Cyclic GMP; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Flurbiprofen; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Indomethacin; Membrane Proteins; Naproxen; Nitric Oxide Donors; Nitroprusside; Phosphodiesterase Inhibitors; Prostaglandin-Endoperoxide Synthases; Purinones; Synovial Membrane; Time Factors | 2005 |
COX inhibitors and bone: A safer impact on osteoblasts by NO-releasing NSAIDs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bone Neoplasms; Cathepsin B; Cell Differentiation; Cell Proliferation; Cyclooxygenase 2 Inhibitors; Humans; Metalloproteases; Naproxen; Nitric Oxide; Osteoblasts; Osteosarcoma; Plasminogen Activators; Tumor Cells, Cultured | 2018 |